What is the next step for a patient with hypotension on maximum doses of epinephrine (adrenaline) and levophed (norepinephrine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hypotension in Patients on Maximum Doses of Epinephrine and Norepinephrine

For patients with persistent hypotension despite maximum doses of epinephrine and norepinephrine, the next step should be adding vasopressin (up to 0.03 U/min) to the treatment regimen. 1

Stepwise Approach to Refractory Hypotension

1. Add Vasopressin

  • Add vasopressin as a bolus 1-2 IU followed by an infusion at 0.03 U/min 1
  • Vasopressin works through a different mechanism than catecholamines, making it effective when patients have developed tachyphylaxis to epinephrine and norepinephrine 2
  • This is particularly important in patients who have experienced maximal vasoconstriction as their internal compensatory response to shock 1

2. Consider Additional Fluid Resuscitation

  • Ensure adequate volume status with crystalloid boluses (up to 20-30 ml/kg) 1
  • Use balanced crystalloids or normal saline based on patient needs 1
  • Consider albumin in addition to crystalloids when patients require substantial amounts of fluid 1

3. Add Glucagon for Beta-Blocker Users

  • For patients on beta-blockers, add IV glucagon 1-2 mg 1, 2
  • Glucagon works through a non-adrenergic pathway to increase cardiac output and may overcome beta-blockade 2

4. Consider Corticosteroids

  • Methylprednisolone (40 mg) followed by stress-dose hydrocortisone (300 mg daily) may improve outcomes in refractory shock 3
  • Corticosteroids can potentiate the effects of vasopressors and address relative adrenal insufficiency 3

5. Escalate Epinephrine Dosing

  • If inadequate response after 10 minutes, consider doubling the bolus dose of epinephrine 1
  • Consider starting an epinephrine infusion (0.05-0.1 μg/kg/min) if more than three epinephrine boluses have been administered 1

Special Considerations

For Anaphylactic Shock

  • In Grade IV reactions (cardiac or respiratory arrest), follow advanced life support guidelines including IV epinephrine 1 mg 1
  • Consider push-dose vasopressin (1 unit IV) as a bridge to continuous infusion in rapidly deteriorating patients 4

For Septic Shock

  • Norepinephrine remains first-line, but adding vasopressin can help decrease norepinephrine dosage and potentially improve outcomes 1, 5
  • Push-dose epinephrine (10-20 μg every 2 minutes) can temporarily resolve hypotension while preparing continuous infusions 6

For Cardiogenic Shock

  • Consider adding dobutamine if there is evidence of persistent hypoperfusion despite adequate fluid loading and vasopressor use 1
  • Monitor for tachyarrhythmias, which are more common with high-dose catecholamines 7

Extreme Measures for Refractory Cases

  • Consider extracorporeal life support where available for patients with persistent shock despite all interventions 1
  • Angiotensin II may be useful for rapid resuscitation of profoundly hypotensive patients 5

Monitoring and Safety

  • Ensure continuous cardiac monitoring and frequent blood pressure measurements 2
  • Watch for signs of excessive vasoconstriction causing organ ischemia/infarction 5
  • Monitor for hyperglycemia, hyperlactatemia, and tachyarrhythmias 2, 5

By following this algorithmic approach, you can systematically address refractory hypotension in patients already on maximum doses of epinephrine and norepinephrine, improving their chances of survival and reducing morbidity.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vasopressor Administration in Critical Care

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Push-Dose Vasopressin for Hypotension in Septic Shock.

The Journal of emergency medicine, 2020

Research

Vasopressor Therapy in the Intensive Care Unit.

Seminars in respiratory and critical care medicine, 2021

Research

Vasopressor and Inotrope Therapy in Cardiac Critical Care.

Journal of intensive care medicine, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.